JAB1对缺氧环境肺癌A549细胞化疗敏感性调控的研究被引量：2

Investigation on human lung cancer cell A549 chemotherapeutic sensitivity regulated by JAB1 in anaerobic condition

导出

摘要目的观察导入pcDNA3.1-HRE-JAB1真核表达质粒的肺癌A549细胞,在低氧环境下对健择(Gemzar)的化疗敏感性,以期找到一种提高肺癌化疗敏感性的方法。方法首先构建缺氧反应元件启动的pcDNA3.1-HRE-JAB1真核表达质粒,鉴定后将该质粒导入肺癌A549细胞。在低氧环境培养过程中加入化疗药物Gemzar,观察空白组(A549)、空载体组(A549+pcD-NA3.1-HRE)和质粒组(A549+pcDNA3.1-HRE-JAB1)肺癌A549细胞对Gemzar的敏感性。采用Real-time PCR和Westernblot分别检测各组肺癌A549细胞中JAB1的mRNA和蛋白表达水平;流式细胞术检测各组肺癌A549细胞周期分布和凋亡情况。结果通过双酶切鉴定,确定构建获得了pcDNA3.1-HRE-JAB1质粒。在有化疗药物Gemzar的情况下,质粒组分别与空白组或空载体组比较,质粒组肺癌A549细胞中JAB1mRNA和蛋白表达水平明显增加(P<0.01),细胞凋亡率明显增加(P<0.01),而细胞周期被明显阻滞于G1期(P<0.01)。结论 JAB1在低氧环境下高表达提高了药物Gemzar化疗的敏感性,这将可能成为一种理想的提高肺癌或其他实体恶性肿瘤化疗敏感性的手段。 Objective To find the Way of improving the lung cancer chemotherapeutic sensitivity, we investigated whether the lung cancer A549 cells introduced eukaryotic expression plasmid pcDNA3.1-HRE-JABI plasmid have the chemotherapeutic sensi- bility to Gemzar in anaerobic condition. Methods We first constructed an eukaryotic expression plasmid pcDNA3. 1-HRE-JAB1 driven by hypoxia response elements promoter. Then, the plasmid was introduced into lung cancer cell line A549. After that, chemo- therapeutic drug such as Gemzar was used to treat the A549 cells in anaerobic condition,and investigated that the normal control （A549） ,the empty vector group（A549＋pcDNA3.1-HRE） and the plasmid group（A549＋pcDNA3.1-HRE-JAB1）A549 cells had chemotherapeutic sensitivity, qRT-PCR and Western blot was used to assay the mRNA and protein level of JAB1. Cell cycle and ap- optosis of A549 cells were also assayed according to flow cytometry. Results According to bi-enzyme digestion evaluation,obtained plasmid was pcDNA3.1-HRE-JAB1 plasmid. The results showed that JAB1 in the A549 was overexpressed after the transfection of pcDNA3.1-HRE-JAB1 compared with the normal control and the empty vector（P〈0.01）. The cell proliferation was arrested at G1 phase and the cell apoptosis was significantly enhanced after the transfection（P〈0.01）. Conclusion JAB1 overexpression signifiantiy increase sensitivity of lung cancer cells to the chemotherapeutic drug Gemzar in anaerobic condition,which might provide an efficient strategy of improving the chemotherapeutic sensitivity of lung cancer or the other cancers. K

作者胡明冬徐剑铖杨昱徐静周长喜毛梅王艺

机构地区第三军医大学新桥医院全军呼吸内科研究所解放军总医院南楼呼吸内科广州军区武汉总医院呼吸内科

出处《重庆医学》 CAS CSCD 北大核心 2012年第23期2345-2347,2351,共4页 Chongqing medicine

基金国家自然科学基金资助项目(30801366)

关键词 A549细胞 JAB1 耐药健择化疗敏感性 A549 cell J AB1 drug resistance Gemzar chemotherapeutic sensitivity

分类号 R734.2 [医药卫生—肿瘤]

引文网络
相关文献

参考文献14

1Toh CK. The changing epidemiology of lung cancer[J]. Methods Mol Biol,2009,472(5) :397-411.
2Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemothera- py? [J]. Oneologist,2004,56(1):31-40.
3Yang QC, Zeng BF, Shi ZM, et al. Inhibition of hypoxia- induced angiogenesis by triehostatin A via suppression of HIF-la activity in human osteosarcoma[J]. J Exp Clin Cancer Res, 2006,25 (10) : 593-599.
4Maher JC, Wangpaichitr M, Savaraj N, et al. Hypoxia-induc- ible factor-1 confers resistance to the glycolytic inhibitor 2-de- oxy-D-glucose[J]. Mol Cancer Ther, 2007,6 (12) : 732-741.
5Semenza GL. HIF-l:mediator of physiological and patho- physiological responses to hypoxia[J]. J Appl Physiol, 2000,88 (10) : 1474-1480.
6Bell EN, Tse MY, Frederiksen LJ, et al. Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells[J]. J Urol, 2007,177(2) : 751-756.
7Yasuda H. Solid tumor physiology and hypoxia-induced chemo/radio-resistance- novel strategy for cancer thera- py:nitric oxide donor as a therapeutic enhancer[J]. Nitric Oxide, 2008,19 (6) : 205-216.
8Xie QC, Hu YD, Wang LL, et al. The co-transfection of p16(INK4a) and p14(ARF) genes intohuman lung cancer cell line A549 and the effects on cell growth and chemosensitivity[J]. Colloids Surf B Biointer- faces,2005,46(3) :188-196.
9Park CM,Park MJ, Kwak H J, et al. Induction of p53-me- diated apoptosis and recovery of chemosensitivity through p53 transduction in human glioblastoma cells by eisplatin [J]. Int J Oncol,2006,28(1) :119-125.
10Kouvaraki MA, Rassidakis GZ, Tian L, et al. Jun activa- tion domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27Kipl [J]. Cancer Res,2003,63(ll) :2977-2981.